VigilantDx Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • 2ndary - Private

VigilantDx General Information

Description

Developer of a thermal contrast amplification technology designed to be used to process a variety of existing lateral flow assay products. The company's technology increases the accuracy of existing body fluid tests by up to eight times, combined with optimized LFA test strips that provide rapid, quantitative, simple-to-use point-of-care information about a patient's disease state, enabling laboratory technicians to access an infrared camera to visually detect positive test results in blood and urine samples to treat patients accurately at a relatively low cost.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 1000 Westgate Drive
  • Suite 9150-G
  • Saint Paul, MN 55114
  • United States
+1 (612)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Biotechnology
Vertical(s)
Corporate Office
  • 1000 Westgate Drive
  • Suite 9150-G
  • Saint Paul, MN 55114
  • United States
+1 (612)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VigilantDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 16-Jul-2025 Completed Generating Revenue
4. Seed Round 22-Nov-2017 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Grant 01-Jan-2017 $600K Completed Generating Revenue
1. University Spin-Out 01-Jan-2014 Completed Startup
To view VigilantDx’s complete valuation and funding history, request access »

VigilantDx Patents

VigilantDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4820746-A1 Designs and methods for the readout of thermal contrast amplification signals Pending 05-Dec-2023
WO-2025122589-A1 Designs and methods for the readout of thermal contrast amplification signals Inactive 05-Dec-2023
EP-4537090-A1 Led thermal contrast assay and reader Pending 06-Jun-2022
US-20250327754-A1 Led thermal contrast assay and reader Pending 06-Jun-2022
WO-2023239725-A1 Led thermal contrast assay and reader Inactive 06-Jun-2022 G01N21/8483
To view VigilantDx’s complete patent history, request access »

VigilantDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VigilantDx FAQs

  • When was VigilantDx founded?

    VigilantDx was founded in 2014.

  • Where is VigilantDx headquartered?

    VigilantDx is headquartered in Saint Paul, MN.

  • What is the size of VigilantDx?

    VigilantDx has 5 total employees.

  • What industry is VigilantDx in?

    VigilantDx’s primary industry is Diagnostic Equipment.

  • Is VigilantDx a private or public company?

    VigilantDx is a Private company.

  • What is VigilantDx’s current revenue?

    The current revenue for VigilantDx is .

  • How much funding has VigilantDx raised over time?

    VigilantDx has raised $1.2M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process